Healthy adults
Conditions
Interventions
Take 5 capsles of test food with water 3 times a day, before breakfast, lunch, and dinner.
Take 5 capsles of placebo with water 3 times a day, before breakfast, lunch, and dinner.
Sponsors
IMEQRD Co., Ltd
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.20 to 64 years old (at the time of submission of an informed consent document). 2.Japanese males and females. 3.BMI of 23.0 kg/m2 to < 30.0 kg/m2 4.Those who tend to feel constipated. 5.Smartphone or PC users (who can input their own data into the electronic diary). 6.Those who can provide their written informed consent.
Exclusion criteria
Exclusion criteria: 1.Those who are currently receiving any types of medicines and/or Chinese medical treatments (except for the medicines that are taken as needed). 2.Those who have or had a severe disease of the liver, heart, kidneys, gastrointestinal tract, respiratory system, endocrine, and metabolism 3.Those who are receiving nutrition therapy or physical therapy under a doctor's supervision. 4.Those who received gastrointestinal surgery (except appendectomy). 5.Those who have been routinely taking medicines, foods with health claim (foods for specified health use, in particular), health foods, or supplements that may affect the body fat and/or bowel movement. 6.Those who cannot abstain from taking health foods during the study period. 7.Those who have a current or previous history of drug and/or food allergies. 8.Smokers. 9.Heavy drinkers. 10.Those who have metals implanted in the body due to surgery etc. 11.Those who have a cardiac pacemaker or an implantable medical device placed in the body. 12.Those who have claustrophobia. 13.Those who work night shifts. 14.Those who are currently undergoing treatment for drug dependence or drug abuse or those who have a past medical history of either of them. 15.Those who are currently pregnant or breastfeeding or those who want to become pregnant during the study period. 16.Those who are currently participating in another clinical trial or those who took a test product and completed another clinical trial in a month. 17.Those who were determined by the principal investigator and the sub investigator to be unsuitable for participation in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visceral fat area | — |
Secondary
| Measure | Time frame |
|---|---|
| Physical examination(Weight, Body mass index, Waist circumference), Subcutaneous fat area, Total fat area, TG, TC, HDL-C, LDL-C, Intestinal flora test, Defecation questionnaire, Questionnaire | — |
Countries
Japan
Contacts
Public ContactHirokuni Kayama
IMEQRD Co., Ltd Planning and Sales Department
Outcome results
None listed